Sanner GmbH, a manufacturer of primary plastic packaging and medical devices, has launched the IDP-Process™, a holistic six-phase development process where customers receive their individual packaging solution. The design of the IDP Process is also suited for serial production and complies with all technical and regulatory requirements.
Inhalers with special spray geometry, especially user-friendly teststrip dispensers, child-resistant closures or breakage-proof dual-chamber syringes – drug packaging requirements are increasing continuously. “A fast and reliable market introduction of new products also requires a matching packaging concept,” says Sanner Managing Director Dirk Mähr. “This is why our IDP-Process™ supports our customers with long-term expertise in the development of all kinds of primary packaging and medical devices. IDP stands for ‘Idea. Design. Product.‘ – we manage customer projects from the first idea right through to serial production, and develop their smart, efficient and safe individual packaging solution.”
At Pharmapack 2017 in Paris, Sanner focuses on six phases, one goal. In the concept phase, the Sanner specialists develop different approaches based on customer demands and regulatory requirements. The criteria for subsequent serial production are already taken into account in this early phase. Once the customer has chosen his favorite solutions, the concepts are further specified in the design phase. In the prototype phase, the required equipment and product samples are qualified and tested. The industrialization phase is all about the final manufacture, installation and qualification of production equipment, as well as defining the parameters for a smooth and efficient production process. This process is validated in the implementation phase. In parallel, all documents required for the approval and registration of both drugs and packaging are issued. Now the roll-out phase can start, while continuous control of serial production ensures consistent product quality.